期刊文献+

艾司西酞普兰与氟西汀治疗抑郁症对照研究 被引量:2

A comparative study of escitalopram and fluoxetine in the treatment of depression
下载PDF
导出
摘要 目的:比较艾司西酞普兰与氟西汀治疗抑郁症的疗效和安全性。方法:将80例抑郁症患者随机分为两组,分别给以予艾司西酞普兰与氟西汀治疗,疗程6周。用汉密尔顿抑郁量表(HAMD)在治疗前及治疗1、2、4、6周评定疗效,用副反应量表(TESS)评定不良反应。结果:两组总体疗效相当,艾司西酞普兰组HAMD评分从第1周就开始显著下降,而氟西汀组HAMD评分从第2周开始显著下降;治疗6周艾司西酞普兰组有效率82.5%,显效率75.0%,氟西汀组分别为80.0%和72.5%。两组不良反应均较轻,安全性好。结论:艾司西酞普兰抗抑郁作用起效较快,疗效及不良反应与氟西汀相当。 Objective To compare the clinical efficacy and safety of escitalpram and fluoxetine in the treatment of depression. Method Eighty patients with depression were treated randomly with escitalopram or fluoxetine for a course of treatment of six weeks, and measured with Hamilton Depressive Scale (HAMD) for efficacy, and Treatment Emergent Symptom Scale (TESS) for side effect before treatment and 1,2, 4, 6 weeks after treatment. Results There was no significant difference in efficacy between the two groups. HAMD scores decreased dramatically at the end of 1st week in escitalopram group and 2nd week in fluoxetine group. The rates of efficacy and marked im- prevement in escitalopram group were 82.5% and 75.0 %, and that in fluoxetine group were 80. 0% and 72.5 %. The side effects of both were fewer. Conclusion Both eseitalopram and fluoxetine are effective antidepressants with fewer side effect. However, eseitalopram takes effect more quickly.
出处 《吉林医学》 CAS 2009年第11期996-998,共3页 Jilin Medical Journal
关键词 艾司西酞普兰 氟西汀 抑郁症 Escitalopram Fluoxetine Depression
  • 相关文献

参考文献9

  • 1Montgomery SA.Clinically relevant effect sizes in depresion[J].Eur Neuropsychopharcol,1994,4 (4):283.
  • 2Braestrup C,Sanchez C.Escitalopram of a unique mechanism of action[J].International Journal of Psychiatry in Clinical Practice,2004,9(1):11.
  • 3Wade A,Michael O Lemming,Bang K Hedegard.Escitalo-pram 10mg/day is effective and well tolerated in a placebo-controlled study in deprssion in primary care[J].International Clinical Psychopharmacology,2002,17(1):95.
  • 4Owens MJ,Knight DL,Nemeroff CB.Second generation SSRIs:human monoamine transporter binding profile of escitalopram and R-fluoxetine[J].Biol Psychiatry,2001,50(2):345.
  • 5Chen FH,Larsen MB,Sanchezc,et al.The S-enantiomer of R,S-citalopram,increases inhibitor binding to the human serotonin transporter by an allosteric mechanism.Comparison with other serotonin transporter inhibitors[J].Eur Neuropsychopharmacology,2005,15(1):193.
  • 6Mork A,Kreilgaard M,Sanchez C.The R-enantiomer of citalopram counteracts escitalopram -induced increase in extracellular 5-HT in the frontal cortex of freely moving rats[J].Neuropharmacology,2003,45(1):167.
  • 7Sanchez C.R-citalopram attenuates anxiolytic effects of escitalopram in a rat ultrasonic vocalization model[J].Eur J Pharmacol,2003,464(1):155.
  • 8Sanchez C,Gruca P,Papp M.R-citalopram counteracts the antidepressant-like effect of escitalopram in a rat chronic mild stressmodel of depression[J].Behav Pharmacol,2003,14(3):465.
  • 9Plenge P,Mellerup ET,Laursen H.Affinity modulation of[3H] imipramine,[3H]paroxetine and[3H]citalopram binding to the 5-HT transporter from brain and platelets[J].Eur J Pharmacol,1991,206(2):243.

同被引文献25

  • 1张亚同,傅得兴.艾司西酞普兰的药理及临床评价[J].中国新药杂志,2006,15(22):1979-1983. 被引量:46
  • 2陈建洪,杨海波,贾一夫.舍曲林与帕罗西汀治疗抑郁症的对照研究[J].现代中西医结合杂志,2007,16(5):606-607. 被引量:10
  • 3司天梅,舒良.关于新抗抑郁药艾司西酞普兰[J].临床精神医学杂志,2007,17(1):68-69. 被引量:124
  • 4钱敏才,沈鑫华,林敏.艾司西酞普兰与舍曲林治疗门诊抑郁症的对照研究[J].上海精神医学,2007,19(2):95-97. 被引量:51
  • 5MONTGOMERY SA.Clinically relevant effect sizes in depression [J].Eur Neuropsychopharcol,1994,4(4):283-284.
  • 6JUNI P,ALTMAN DG,EGGER M.Systematic reviews in health care:assessing the quality of controlled clinical trials[J].BMJ, 2001,323(7303):42-46.
  • 7LETTH S,BLUMENTHAL JA,BABYAK MA.et al.Depression as a risk factor for coronary artery disease:evidence,mechanisms, and treatment[J].Psychosomat Med,2004,66(3):305-315.
  • 8BURKE WJ,GERGEL I,BOSE A.Fixed-dose trial of the single isomer SSRI easitalopram in depressed outpatients[J].J Clin Psychiatry,2002,63(4):331-339.
  • 9Claus B,Connie S. Escitalopram:a unique mechanism of action[J].International Journal of Psychiatry in Clinical Practice,2004,(s 1):11.
  • 10Colonna L,Andersen HF,Reines EH. A randomized,double blind,24 week study of escitalopram(10 mg/day)versus citalopram(20 mg/day)in primary care patients with major depressive disorder[J].Current Medical Research and Opinion,2005,(10):1659.

引证文献2

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部